Exscientia claims world first as AI-created drug enters clin...

Drug discovery firm Exscientia has claimed a world first after announcing that the first precision engineered drug generated by artificial intelligence (AI) is entering clinical trials.

PatchAi launches virtual assistant for clinical trial patien...

The Italian startup PatchAi has launched an empathic virtual assistant designed to help patients taking part in the clinical trial process.

Poor data hindering machine learning in drug R&D

A lack of high-quality data is hindering use of machine learning in drug development, according to a new report from the US government.

Artificial intelligence and the future of rep visits

As access to healthcare professionals (HCPs) declines, the challenges facing sales representatives continue to increase: less time with HCPs, Sunshine Act restrictions, and integration of p

AI system detects 'hypos' using ECG readout

Researchers from a UK university have devised an artificial intelligence (AI)-based system that can detect low glucose levels using an ECG readout without a fingerprick test, in healthy pat

AI specialist Exscientia signs drug discovery tie-up with Ba...